HSBC Holdings’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Buy |
19,503
+3,408
| +21% | +$39.7K | ﹤0.01% | 2155 |
|
|
2025
Q1 | $189K | Buy |
16,095
+3,988
| +33% | +$46.8K | ﹤0.01% | 2189 |
|
|
2024
Q4 | $226K | Buy |
+12,107
| New | +$226K | ﹤0.01% | 2237 |
|
|
2024
Q3 | – | Sell |
-17,038
| Closed | -$350K | – | 2676 |
|
|
2024
Q2 | $350K | Sell |
17,038
-16,640
| -49% | -$342K | ﹤0.01% | 1830 |
|
|
2024
Q1 | $495K | Sell |
33,678
-33,645
| -50% | -$495K | ﹤0.01% | 1719 |
|
|
2023
Q4 | $699K | Buy |
67,323
+19,258
| +40% | +$200K | ﹤0.01% | 1519 |
|
|
2023
Q3 | $377K | Buy |
48,065
+13,736
| +40% | +$108K | ﹤0.01% | 1630 |
|
|
2023
Q2 | $347K | Buy |
34,329
+8,877
| +35% | +$89.6K | ﹤0.01% | 1682 |
|
|
2023
Q1 | $225K | Buy |
25,452
+1,707
| +7% | +$15.1K | ﹤0.01% | 1919 |
|
|
2022
Q4 | $260K | Buy |
23,745
+11,571
| +95% | +$126K | ﹤0.01% | 2168 |
|
|
2022
Q3 | $162K | Buy |
+12,174
| New | +$162K | ﹤0.01% | 2244 |
|
|
2022
Q2 | – | Sell |
-11,615
| Closed | -$165K | – | 2916 |
|
|
2022
Q1 | $165K | Buy |
+11,615
| New | +$165K | ﹤0.01% | 2651 |
|